Evidence map›Paper›PMID 23677916›Full record

ArticleCirculation. Cardiovascular genetics2013

Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.

Nicole J Boczek, Jabe M Best, David J Tester, John R Giudicessi, Sumit Middha, Jared M Evans, Timothy J Kamp, Michael J Ackerman

Open access · greenAbstract read
In one paragraph

Article in Circulation. Cardiovascular genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Geno- and phenotypic characteristics and clinical outcomes ofFrontiers in cardiovascular medicine · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Role of CaArchives of toxicology · 2023
    Review
  18. CACNA1C-Related Channelopathies.Handbook of experimental pharmacology · 2023
    Review
  19. Analysis ofGenes · 2022
    Article
  20. Increased CaScientific reports · 2022
    Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicole J BoczekCenter for Translational Science Activities, Mayo Graduate School, Mayo Clinic, Rochester, MN 55905, USA.
Jabe M Best
David J Tester
John R Giudicessi
Sumit Middha
Jared M Evans
Timothy J Kamp
Michael J Ackerman
University of Wisconsin–Madison · US

Funding

INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
RYANODINE RECEPTORS, Ca2+-TRIGGERED ARRHYTHMIAS AND HCMP01HL094291 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MOSS, RICHARD L · 2009 to 2013
$9.7M
Caveolae and L-type Calcium Channels in CardiomyocytesR01HL078878 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BALIJEPALLI, RAVI CHANDRA, KAMP, TIMOTHY J. · 2007 to 2016
$3.1M
The Role of The Transient Outward Current In Genetically Elusive Sudden DeathF30HL106993 · NHLBI · MAYO CLINIC ROCHESTER · PI GIUDICESSI, JOHN R. · 2011 to 2014
$134k
NHLBI NIH HHS F30 HL106993NHLBI NIH HHS F30-HL106993NHLBI NIH HHS P01 HL094291NHLBI NIH HHS PPG HL94291NHLBI NIH HHS R01 HL078878NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

backgroundLong QT syndrome (LQTS) is the most common cardiac channelopathy with 15 elucidated LQTS-susceptibility genes. Approximately 20% of LQTS cases remain genetically elusive. METHODS AND

resultsWe combined whole-exome sequencing and bioinformatic/systems biology to identify the pathogenic substrate responsible for nonsyndromic, genotype-negative, autosomal dominant LQTS in a multigenerational pedigree, and we established the spectrum and prevalence of variants in the elucidated gene among a cohort of 102 unrelated patients with "genotype-negative/phenotype-positive" LQTS. Whole-exome sequencing was used on 3 members within a genotype-negative/phenotype-positive family. Genomic triangulation combined with bioinformatic tools and ranking algorithms led to the identification of a CACNA1C mutation. This mutation, Pro857Arg-CACNA1C, cosegregated with the disease within the pedigree, was ranked by 3 disease-network algorithms as the most probable LQTS-susceptibility gene and involves a conserved residue localizing to the proline, gltamic acid, serine, and threonine (PEST) domain in the II-III linker. Functional studies reveal that Pro857Arg-CACNA1C leads to a gain of function with increased ICa,L and increased surface membrane expression of the channel compared to wild type. Subsequent mutational analysis identified 3 additional variants within CACNA1C in our cohort of 102 unrelated cases of genotype-negative/phenotype-positive LQTS. Two of these variants also involve conserved residues within Cav1.2's PEST domain.

conclusionsThis study provides evidence that coupling whole-exome sequencing and bioinformatic/systems biology is an effective strategy for the identification of potential disease-causing genes/mutations. The identification of a functional CACNA1C mutation cosegregating with disease in a single pedigree suggests that CACNA1C perturbations may underlie autosomal dominant LQTS in the absence of Timothy syndrome.

Indexed as

ExomeMutation, MissenseAdolescentAdultBase SequenceCalcium Channels, L-TypeCohort StudiesDNA Mutational AnalysisFemaleGenes, DominantHumansLong QT SyndromeMaleMiddle AgedMolecular Sequence DataPedigreeCACNA1C protein, humanCalcium Channels, L-Type

Identifiers

PMID23677916
PMCPMC3760222
OpenAlexW1987690552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.